论文部分内容阅读
目的:观察依达拉奉治疗急性高血压脑出血的临床效果。方法:280例急性高血压脑出血患者随机分为治疗组(n=140)和对照组(n=140),对照组给予常规治疗,治疗组在常规治疗基础上,给予依达拉奉30 mg+生理盐水100 mL静脉滴注,30 min内滴完,2次/d,共14 d。比较2组治疗前、后神经功能缺损评分及日常生活能力评分。结果:治疗14 d后,治疗组神经功能缺损评分低于对照组(P<0.05),日常生活能力评分高于对照组(P<0.05);治疗组显效率和有效率优于对照组(P<0.05)。结论:依达拉奉可促进脑出血患者的神经功能康复,改善神经功能缺损症状。
Objective: To observe the clinical effect of edaravone in treatment of acute hypertensive intracerebral hemorrhage. Methods: 280 patients with acute hypertensive intracerebral hemorrhage were randomly divided into treatment group (n = 140) and control group (n = 140). The control group was given routine treatment. The treatment group was given edaravone 30 mg + Saline 100 mL intravenously, drip finished within 30 min, 2 times / d, a total of 14 d. The scores of neurological deficits and daily living ability were compared between the two groups before and after treatment. Results: After 14 days of treatment, the score of neurological deficit in the treatment group was lower than that in the control group (P <0.05), and the score of daily living ability was higher than that of the control group (P <0.05). The effective rate and effective rate of the treatment group were better than those of the control group <0.05). Conclusion: Edaravone can promote the neurological rehabilitation of patients with cerebral hemorrhage and improve the symptoms of neurological deficits.